A Clinical Study Evaluating Inhaled Aviptadil on COVID-19
Clinical trial NCT04844580 · COMPLETED
Trial details
- NCT number
- NCT04844580
- Sponsor
- Centurion Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-10
- Primary completion
- 2022-06-07
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.